Home > Quotes > CEMP > Press Releases
CEMP

Cempra, Inc. Press Releases

$6.81
*  
0.07
  negative  
1.04%
Get CEMP Alerts
*Delayed - data as of May 22, 2013 10:46 ET 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
View:    CEMP Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)
05/20/2013 8:00AM - PR Newswire

Cempra, Inc. Signs Exclusive License and Development Agreement for Solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation in Japan
05/13/2013 4:05PM - PR Newswire

Cempra to Present Data on Solithromycin's (CEM-101) Potential Against Urogenital Infections and Multidrug-Resistant Pathogens at ECCMID
04/26/2013 7:01PM - PR Newswire

Cempra, Inc. Reports First Quarter 2013 Financial and Operating Results
04/25/2013 4:05PM - PR Newswire

Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference
04/24/2013 4:05PM - PR Newswire

Cempra, Inc. to Report First Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on April 25, 2013
04/18/2013 4:05PM - PR Newswire

Cempra, Inc. Reports Fourth Quarter and Full Year 2012 Financial and Operating Results
02/28/2013 4:05PM - PR Newswire

Cempra, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference
02/26/2013 4:05PM - PR Newswire